Table 2. Multivariate analysis using the stepwise Cox regression procedures.
|
Univariatea |
Multivariateb |
||
---|---|---|---|---|
Variables | P-value | HR | 95% CI | P-value |
Sex | ||||
Male vs female |
0.9583 |
2.749 |
1.134–6.665 |
0.0252 |
Age | ||||
⩾60 vs <60 |
0.0391 |
5.649 |
1.992–16.12 |
0.0011 |
Location | ||||
U vs ML |
0.0262 |
|
— |
|
Histological type | ||||
Undifferentiated vs differentiated |
0.8468 |
|
— |
|
Tumor size (mm) | ||||
⩾40 vs <40 |
<0.0001 |
|
— |
|
Venous invasion | ||||
Positive vs negative |
<0.0001 |
5.681 |
2.173–14.92 |
0.0004 |
Lymphatic invasion | ||||
Positive vs negative |
<0.0001 |
|
— |
|
pT-stage | ||||
T3-4 vs T1-2 |
<0.0001 |
6.493 |
1.385–27.77 |
0.0177 |
pN-stage | ||||
N2-3 vs N0-1 |
<0.0001 |
17.54 |
4.672–66.66 |
<0.0001 |
SMYD2 expression | ||||
High vs low | 0.0073 | 4.258 | 1.690–10.72 | 0.0021 |
Abbreviations: CI=confidence interval; HR=hazard ratio; ML=middle and lower; SMYD2=SET and MYND domain-containing protein 2; U=upper. Statistically significant values are in bold.
Kaplan–Meier method, and the statistical significance was determined by log-rank test.
Multivariate survival analysis was performed using Cox's proportional hazard model.